Frank Morich - Net Worth and Insider Trading

Frank Morich Net Worth

The estimated net worth of Frank Morich is at least $47,040 dollars as of 2024-05-24. Frank Morich is the Director of Cue Biopharma Inc and owns about 28,000 shares of Cue Biopharma Inc (CUE) stock worth over $47,040. Details can be seen in Frank Morich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frank Morich has not made any transactions after 2022-05-27 and currently still holds the listed stock(s).

Transaction Summary of Frank Morich

To

Frank Morich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Frank Morich owns 2 companies in total, including Cue Biopharma Inc (CUE) , and Perspective Therapeutics Inc (CATX) .

Click here to see the complete history of Frank Morich’s form 4 insider trades.

Insider Ownership Summary of Frank Morich

Ticker Comapny Transaction Date Type of Owner
CUE Cue Biopharma Inc 2022-05-27 director
CATX Perspective Therapeutics Inc 2023-02-03 director

Frank Morich Latest Holdings Summary

Frank Morich currently owns a total of 1 stock. Frank Morich owns 28,000 shares of Cue Biopharma Inc (CUE) as of May 27, 2022, with a value of $47,040.

Latest Holdings of Frank Morich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CUE Cue Biopharma Inc 2022-05-27 28,000 1.68 47,040

Holding Weightings of Frank Morich


Frank Morich Form 4 Trading Tracker

According to the SEC Form 4 filings, Frank Morich has made a total of 1 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cue Biopharma Inc is the acquisition of 28,000 shares on May 27, 2022, which cost Frank Morich around $105,000.

Insider Trading History of Frank Morich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Frank Morich Trading Performance

GuruFocus tracks the stock performance after each of Frank Morich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank Morich is -27.2%. GuruFocus also compares Frank Morich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank Morich within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Frank Morich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Frank Morich

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -26.17
Relative Return to S&P 500(%) -19.96

Frank Morich Ownership Network

Ownership Network List of Frank Morich

No Data

Ownership Network Relation of Frank Morich


Frank Morich Owned Company Details

What does Cue Biopharma Inc do?

Who are the key executives at Cue Biopharma Inc?

Frank Morich is the director of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .

Cue Biopharma Inc (CUE) Insider Trades Summary

Over the past 18 months, Frank Morich made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net sale of 9,325 shares made by Peter A Kiener , a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .

In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,325 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net sale of 2,325 shares.

Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cue Biopharma Inc Insider Transactions

No Available Data

Frank Morich Mailing Address

Above is the net worth, insider trading, and ownership report for Frank Morich. You might contact Frank Morich via mailing address: 40 Guest Street, Boston Ma 02135.

Discussions on Frank Morich

No discussions yet.